Evidence map›Paper›PMID 39927650›Full record

ReviewMolecular oncology2025

Addressing persistent challenges in digital image analysis of cancer tissue: resources developed from a hackathon.

Sandhya Prabhakaran, Clarence Yapp, Gregory J Baker, Johanna Beyer, Young Hwan Chang, Allison L Creason, Robert Krueger, Jeremy Muhlich, Nathan Heath Patterson, Kevin Sidak and 7 more

Abstract readReview
In one paragraph

Review in Molecular oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Sandhya PrabhakaranMoffitt Cancer Center, Tampa, FL, USA.ORCID https://orcid.org/0000-0002-9537-507X
Clarence YappLaboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA.ORCID https://orcid.org/0000-0003-1144-5710
Gregory J BakerLaboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA.ORCID https://orcid.org/0000-0002-5196-3961
Johanna BeyerSchool of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.
Young Hwan ChangDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.ORCID https://orcid.org/0000-0001-8764-1959
Allison L CreasonDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.ORCID https://orcid.org/0000-0001-5724-1276
Robert KruegerHarvard University, Cambridge, MA, USA.
Jeremy MuhlichHarvard Medical School, Boston, MA, USA.
Nathan Heath PattersonAspect Analytics, Genk, Belgium.ORCID https://orcid.org/0000-0002-0064-1583
Kevin SidakHarvard University, Cambridge, MA, USA.
Damir SudarQuantitative Imaging Systems, Monroeville, PA, USA.ORCID https://orcid.org/0000-0002-2510-7272
Adam J TaylorSage Bionetworks, Seattle, WA, USA.ORCID https://orcid.org/0000-0003-0501-8886
Luke TernesDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.ORCID https://orcid.org/0000-0002-7739-0292
Jakob TroidlSchool of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.
Xie YubinMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Artem SokolovLaboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA.ORCID https://orcid.org/0000-0002-8056-0504
Darren R TysonVanderbilt University School of Medicine, Nashville, TN, USA.ORCID https://orcid.org/0000-0002-3272-4308

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Human Tumor Atlas Network: Data Coordinating Center SupplementU24CA233243 · NCI · DANA-FARBER CANCER INST · PI ROBERT C GENTLEMAN, Nikolaus Schultz · 2018 to 2026
$29.1M
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule DrugsU54CA225088 · NCI · HARVARD MEDICAL SCHOOL · PI SOKOLOV, ARTEM · 2018 to 2022
$10.8M
Understanding the Impact of Microscale and Nanoscale Heterogeneity and ResistanceU54CA209988 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI DEMIR, EMEK, HEISER, LAURA MADELINE · 2017 to 2021
$10.3M
Omic and Multidimensional Spatial Atlas of Metastatic Breast CancerU2CCA233280 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI GOECKS, JEREMY · 2018 to 2023
$9.7M
Single-Cell Biology and Data Analysis Shared Resource (SCB-DA SR)U54CA217450 · NCI · VANDERBILT UNIVERSITY · PI QUARANTA, VITO · 2018 to 2022
$8.5M
Research Specialist in Cancer Systems BiologyR50CA243783 · NCI · VANDERBILT UNIVERSITY · PI TYSON, DARREN R · 2019 to 2023
$781k
National Science Foundation IIS-1901030National Science Foundation NCS-FO-2124179NCI NIH HHS 3U54CA225088-04S1NCI NIH HHS P30 CA008748NCI NIH HHS R50 CA243783NCI NIH HHS R50CA243783NCI NIH HHS U24 CA233243NCI NIH HHS U2C-CA233262NCI NIH HHS U2CCA233280NCI NIH HHS U54 CA209988NCI NIH HHS U54CA209988NCI NIH HHS U54 CA217450NCI NIH HHS U54CA217450NCI NIH HHS U54 CA225088NCI NIH HHS U54CA225088
6 · The paper itself

Abstract

The National Cancer Institute (NCI) supports numerous research consortia that rely on imaging technologies to study cancerous tissues. To foster collaboration and innovation in this field, the Image Analysis Working Group (IAWG) was created in 2019. As multiplexed imaging techniques grow in scale and complexity, more advanced computational methods are required beyond traditional approaches like segmentation and pixel intensity quantification. In 2022, the IAWG held a virtual hackathon focused on addressing challenges in analyzing complex, high-dimensional datasets from fixed cancer tissues. The hackathon addressed key challenges in three areas: (1) cell type classification and assessment, (2) spatial data visualization and translation, and (3) scaling image analysis for large, multi-terabyte datasets. Participants explored the limitations of current automated analysis tools, developed potential solutions, and made significant progress during the hackathon. Here we provide a summary of the efforts and resultant resources and highlight remaining challenges facing the research community as emerging technologies are integrated into diverse imaging modalities and data analysis platforms.

Indexed as

Image Processing, Computer-AssistedNeoplasmsHumansartifact removalartifactscancercomputational scalabilitydomain representationimage analysis

Identifiers

PMID39927650
PMCPMC12161476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.